Crispr Therapeutics Ag (CRSP)

Cash & Equivalents

$291.34M

Quarterly · Period ending: · USD

CRSP logo

CRSP Cash & Equivalents

Latest reported$291.34M
CRSP Quarterly Cash & Equivalents ($155.96M → $291.34M)
High-resolution chart · PNG

CRSP cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
291,337,000
423,308,000
355,188,000
290,011,000
197,132,000
235,184,000
298,257,000
225,670,000
484,472,000
707,427,000
389,477,000
527,765,000
444,796,000
344,407,000
211,885,000
494,151,000
496,893,000
683,906,000
923,031,000
1,011,548,000
1,646,646,000
1,126,059,000
1,168,620,000
1,041,417,000
945,068,000
889,712,000
943,771,000
629,717,000
427,885,000
437,549,000
456,649,000
487,295,000
319,737,000
341,767,000
239,758,000
253,519,000
272,264,000
288,872,000
315,520,000
228,613,000
246,849,000
200,600,000
155,961,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.